Home
User Guide
What's in a MalaCard Search Guide Our Sources
Analysis Tools
GeneCards GeneAnalytics GeneAlaCart PathCards VarElect
News and Views Disease Lists/Categories
About
About MalaCards Datasets Our Publications Weizmann Institute LifeMap Discovery® Terms of Use MalaCards Team
MCID: OBS037
MIFTS: 44

Obesity-Hypoventilation Syndrome

Categories: Blood diseases, Metabolic diseases, Respiratory diseases
Genes Tissues Related diseases Publications Pathways Symptoms & Phenotypes Drugs
Sources

Aliases & Classifications for Obesity-Hypoventilation Syndrome

About this section

MalaCards integrated aliases for Obesity-Hypoventilation Syndrome:

Name: Obesity-Hypoventilation Syndrome 57 54
Obesity Hypoventilation Syndrome 36 62 17 70
Pickwickian Syndrome 57

Characteristics:

OMIM®:

57 (Updated 05-Apr-2021)
Inheritance:
autosomal recessive


HPO:

31
obesity-hypoventilation syndrome:
Inheritance autosomal recessive inheritance


Classifications:

MalaCards categories:
Global: Metabolic diseases
Anatomical: Respiratory diseases Blood diseases
See all MalaCards categories (disease lists)


External Ids:

OMIM® 57 257500
KEGG 36 H01715
MedGen 41 C0031880
UMLS 70 C0031880
Sources

Summaries for Obesity-Hypoventilation Syndrome

About this section
KEGG : 36 Obesity hypoventilation syndrome (OHS) is defined as the triad of obesity (BMI of 30 or higher), daytime hypoventilation, and sleep-disordered breathing in the absence of any other cause of hypoventilation. The features include marked obesity, somnolence, twitching, cyanosis, periodic respiration, polycythemia, and right ventricular hypertrophy and failure. Patients with untreated OHS have a significant risk of death. While continuous positive airway pressure (CPAP) treatments may temporize cardiopulmonary disease progression, simultaneous pursuit of weight reduction is central to long-term management of this condition.

MalaCards based summary : Obesity-Hypoventilation Syndrome, also known as obesity hypoventilation syndrome, is related to sleep apnea and sleep disorder, and has symptoms including obesity, metabolically benign An important gene associated with Obesity-Hypoventilation Syndrome is LEP (Leptin), and among its related pathways/superpathways are Common Cytokine Receptor Gamma-Chain Family Signaling Pathways and Circadian rythm related genes. The drugs Acetazolamide and Anticonvulsants have been mentioned in the context of this disorder. Affiliated tissues include heart, lung and endothelial, and related phenotypes are obesity and cyanosis

PubMed Health : 62 About obesity hypoventilation syndrome: Obesity hypoventilation (HI-po-ven-tih-LA-shun) syndrome (OHS) is a breathing disorder that affects some obese people. In OHS, poor breathing results in too much carbon dioxide (hypoventilation) and too little oxygen in the blood (hypoxemia). OHS sometimes is called Pickwickian syndrome.

Wikipedia : 73 Obesity hypoventilation syndrome (OHS) is a condition in which severely overweight people fail to... more...

More information from OMIM: 257500
Sources

Related Diseases for Obesity-Hypoventilation Syndrome

About this section

Diseases related to Obesity-Hypoventilation Syndrome via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 198)
# Related Disease Score Top Affiliating Genes
1 sleep apnea 30.7 RETN LEP IL6 ADIPOQ
2 sleep disorder 30.5 LEP IL6 ADIPOQ
3 apnea, obstructive sleep 30.3 RETN LEP IL6 ADIPOQ
4 acanthosis nigricans 30.1 LEP ADIPOQ
5 leptin deficiency or dysfunction 29.8 RETN LEP IL6 ADIPOQ
6 body mass index quantitative trait locus 11 29.8 RETN LEPQTL1 LEP IL6 CCL5 ADIPOQ
7 uremia 29.6 RETN LEP IL6
8 hypothyroidism 29.5 RETN LEPQTL1 LEP ADIPOQ
9 chronic kidney disease 29.3 RETN LEP IL6 ADIPOQ
10 asthma 29.2 LEP IL6 CCL5 ADIPOQ
11 prader-willi syndrome 29.0 RETN LEPQTL1 LEP IL6 ADIPOQ
12 kidney disease 28.9 RETN LEP IL6 CCL5 ADIPOQ
13 heart disease 28.8 RETN LEP IL6 CCL5 ADIPOQ
14 body mass index quantitative trait locus 9 11.0
15 body mass index quantitative trait locus 8 11.0
16 body mass index quantitative trait locus 4 11.0
17 body mass index quantitative trait locus 10 11.0
18 body mass index quantitative trait locus 7 11.0
19 body mass index quantitative trait locus 12 11.0
20 body mass index quantitative trait locus 14 11.0
21 body mass index quantitative trait locus 18 11.0
22 body mass index quantitative trait locus 19 11.0
23 respiratory failure 10.7
24 pulmonary hypertension 10.7
25 pulmonary disease, chronic obstructive 10.4
26 body mass index quantitative trait locus 1 10.3
27 congestive heart failure 10.3
28 polycythemia 10.3
29 lung disease 10.3
30 neuromuscular disease 10.2
31 pulmonary embolism 10.2
32 nontuberculous mycobacterial lung disease 10.2 LEP ADIPOQ
33 papilledema 10.2
34 complete generalized lipodystrophy 10.2 LEP ADIPOQ
35 mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome 10.2 LEP ADIPOQ
36 lipodystrophy, familial partial, type 2 10.1 LEP ADIPOQ
37 hypothalamic obesity 10.1 RETN LEP
38 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.1
39 cyanosis, transient neonatal 10.1
40 proteinuria, chronic benign 10.1
41 patent foramen ovale 10.1
42 hypoxia 10.1
43 lipedema 10.1 LEP IL6
44 narcolepsy 10.1
45 atypical depressive disorder 10.1 LEP IL6
46 intracranial hypertension 10.0 RETN ADIPOQ
47 post-thrombotic syndrome 10.0 IL6 ADIPOQ
48 scorpion envenomation 10.0 IL6 CCL5
49 arteriosclerosis obliterans 10.0 IL6 ADIPOQ
50 angina pectoris 10.0 IL6 ADIPOQ

Graphical network of the top 20 diseases related to Obesity-Hypoventilation Syndrome:



Diseases related to Obesity-Hypoventilation Syndrome
Sources

Symptoms & Phenotypes for Obesity-Hypoventilation Syndrome

About this section

Human phenotypes related to Obesity-Hypoventilation Syndrome:

31
# Description HPO Frequency HPO Source Accession
1 obesity 31 HP:0001513
2 cyanosis 31 HP:0000961
3 excessive daytime somnolence 31 HP:0001262
4 hypoventilation 31 HP:0002791

Symptoms via clinical synopsis from OMIM®:

57 (Updated 05-Apr-2021)
Growth:
obesity

Neuro:
somnolence
muscular twitching

Skin:
cyanosis

Resp:
periodic breathing

Clinical features from OMIM®:

257500 (Updated 05-Apr-2021)

UMLS symptoms related to Obesity-Hypoventilation Syndrome:


obesity, metabolically benign

MGI Mouse Phenotypes related to Obesity-Hypoventilation Syndrome:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 adipose tissue MP:0005375 8.92 ADIPOQ IL6 LEP RETN
Sources

Drugs & Therapeutics for Obesity-Hypoventilation Syndrome

About this section

PubMed Health treatment related to Obesity-Hypoventilation Syndrome: 62

Treatments for obesity hypoventilation syndrome (OHS) include breathing support, weight loss, and medicines. The goals of treating OHS may include: Supporting and aiding your breathing Achieving major weight loss Treating underlying and related conditions

Drugs for Obesity-Hypoventilation Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 12)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Acetazolamide Approved, Vet_approved Phase 3 59-66-5 1986
2 Anticonvulsants Phase 3
3 diuretics Phase 3
4 Carbonic Anhydrase Inhibitors Phase 3
5
Ethanol Approved 64-17-5 702
6
tannic acid Approved 1401-55-4
7
Benzocaine Approved, Investigational 1994-09-7, 94-09-7 2337
8 Anesthetics
9 Central Nervous System Stimulants
10 Hypnotics and Sedatives
11 Pharmaceutical Solutions
12 Calamus

Interventional clinical trials:

(show all 50)
# Name Status NCT ID Phase Drugs
1 Medium Cost Effectiveness of Automated Non-Invasive Ventilation Outpatient Set Up vs Standard Fixed Level Non-Invasive Ventilation Inpatient Set Up In Obese Patients With Chronic Respiratory Failure Completed NCT02342899 Phase 3
2 Effects of Acetazolamide on the Duration of Mechanical Ventilation in Patients With Metabolic Alkalosis. Phase III Multicenter Double-blinded Clinical Trial. Completed NCT01499485 Phase 3 Acetazolamide;Placebo
3 A Clinical Trial to Optimise Patient-ventilator Interaction in Patients With Chronic Respiratory Failure Completed NCT01371149 Phase 2
4 Randomized Trial Comparing Telemedicine Monitoring and Titration in Patients Initiating Non-invasive Ventilation With Usual Care (TELEMOTINIV Study) Unknown status NCT01560741 Phase 1
5 Postoperative Complications in Patients With Obesity Hypoventilation Syndrome Based on Base Excess- OHBE Study: A National, Multicenter, Observational Cohort Study Unknown status NCT02980770
6 Interest of Using Nocturnal Polysomnography for Non-Invasive Ventilation (NIV) Settings' Optimization in Obesity-Hypoventilation Syndrome (OHS) Unknown status NCT00603096
7 Autotitrating Non-invasive Ventilation (NIV) Versus Standard NIV; a Randomised Crossover Trial in Patients With Acute Exacerbation of Chronic Respiratory Failure Unknown status NCT01174316
8 Effectiveness Monitoring of Home Non-invasive Mechanical Ventilation by Pressure and Flow-time Signals Analysis Integrated on Digital Diagnosis Platform. Unknown status NCT03085537
9 A Pilot Study to Investigate the Physiological and Clinical Effects of Heated Humidification During Non-Invasive Ventilation Unknown status NCT01372072
10 Response to NonInvasive Mechanical Ventilation According to the Breathing Pattern Unknown status NCT01991535
11 Prevalence of Obesity Hypoventilation Syndrome in Subjects With Obesity Referred to Clinical (Medical Analysis) Laboratories for Regular Follow-up Completed NCT01903135
12 Clinical Benefits and Tolerance to a New Ventilatory Mode in Patients With Obesity Hypoventilation Syndrome (OHS). Completed NCT01757444
13 A Trial of Rehabilitation in Obesity Hypoventilation Syndrome (OHS) Completed NCT01483716
14 Impact of Non-intentional Leaks on Breathing Pattern and Work of Breathing During Non-invasive Ventilation: Study in Awakened Healthy Subjects and Awakened Obesity Hypoventilation Syndrome(OHS)Patients and During the Sleep in OHS Patients. Completed NCT00983411
15 The Obesity-Hypoventilation Syndrome: A Study Of Clinical Characteristics And Predictive Factors Of Response To Treatment With Continuous Positive Airway Pressure (CPAP) And Non-Invasive Ventilation (NIV) Completed NCT00938977
16 Prevalence Rate, and Clinical Characteristics of Obesity Hypoventilation Syndrome Via Screening Patients Admitted to Medical Intensive Care Units Completed NCT02934581
17 Comparison of Two Noninvasive Positive Pressure Ventilation Devices Using Target Volume Modes in Obesity Hypoventilation Syndrome (OHS): A Pilot Randomized Crossover Controlled Trial Completed NCT01748656
18 PAP Therapy Compliance in Patients With Obesity Hypoventilation Syndrome Completed NCT03449641
19 Mid-and Long-term Efficacy of Ventilation Non-invasive and Continuos Positive Airway Pressure in Obesity Hypoventilation Syndrome Completed NCT01405976
20 Randomized Controlled Trial Evaluating the Feasibility of AVAPS-AE vs. CPAP vs.Bilevel Pressure Support Ventilation in Obesity Hypoventilation Syndrome Completed NCT01368614
21 Improvement of Cardiac Function and Neural Respiratory Drive Following Set up of Non-invasive Ventilation in Patients With Hypercapnic Respiratory Failure Caused by Obesity Hypoventilation Syndrome Completed NCT02699112
22 Usefulness of Transcutaneous Capnography to Assess Residual Hypoventilation in Obesity-Hypoventilation Syndrom Treated by Non Invasive Ventilation at Home : a Prospective Study Completed NCT03572712
23 Obesity in Sleep Medicine - Focusing on OHS Phenotypes Completed NCT04570540
24 Contribution of Average Volume Assured Pressure Support (AVAPS) to Efficacy of bi-Level Pressure Support Nocturnal Ventilation and Impact on Sleep Structure Completed NCT00479284
25 Effect of Auto-trilevel Ventilator on Patients With Obstructive Sleep Apnea Hypopnea Syndrome and Obesity Completed NCT01553227
26 Use of Ventilator Monitoring for Early Detection of Exacerbations of Chronic Lung Disease Completed NCT01644162
27 Factors Associated With Chronic Respiratory Failure in Obesity: A Cross-sectional Study Completed NCT01380418
28 Medico-economic and Quality of Life Evaluations in Obese Patients Followed by Medical Analysis Laboratories Recruiting NCT03861468
29 Multimodal Measurement of Respiratory Muscle Strength by Using Volitional and Non-volitional Tests in Patients With Obesity Hypoventilation Syndrome (OHS), Obesity-associated Hypoventilation and OHS-Risk-Patients to Evaluate Pathophysiological Determinants and Predictors for the Presence of a Sleep-related Hypoventilation Requiring Treatment in Obese Patients Recruiting NCT03854058
30 Ketogenic Diet for Obesity Hypoventilation Syndrome Recruiting NCT04108819
31 Effectiveness of Noninvasive Ventilation Adjusted Automatically in the Obesity Hypoventilation Syndrome Recruiting NCT04327336
32 Pathophysiology of Hypoventilation in Obesity and Effects of Bariatric Intervention: PHOEBI Study Recruiting NCT04025528
33 Multi-center, National, Randomized, Exploratory Study Evaluating Telemonitoring and Experimentation in Telemedicine for the Improvement of Healthcare Pathways (ETAPES Program) Compared to Standard of Care in Patients With Chronic Respiratory Failure Receiving Non-invasive Home Ventilation (e-VENT) Recruiting NCT04615078
34 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity Recruiting NCT04100616
35 Prevalence of Right Ventricular Dysfunction in Acute Exacerbation of Chronic Respiratory Diseases and Its Impact on Outcomes Recruiting NCT04098094
36 Predictive Factors of Obesity-hypoventilation Syndrome (OHS) Among Obese Subjects- ETUDE COHYPOB - Active, not recruiting NCT02021448
37 The Debated Role of Sleep Studies in Patients Under Established Home Mechanical Ventilation Active, not recruiting NCT03506906
38 Evaluation of Effects of Positive End-expiratory Pressure (PEEP) on Lung and Heart Functions in Spontaneous Breathing Obese Subjects. Enrolling by invitation NCT02523352
39 Impact of Noninvasive Ventilation on Resting Energy Expenditure in Patients With Obesity Hypoventilation Syndrome Treated by Long-term Home Noninvasive Ventilation. Not yet recruiting NCT04474587
40 Evaluation of An Optical Measurement Algorithm Combined With Patient and Provider Input to Reduce Mask Exchanges During Initial Positive Airway Pressure Therapy Not yet recruiting NCT04688125
41 "Mid- and Long-term Effectiveness of Positive Airway Pressure in OHS After an Acute-on-chronic Hypercapnic Respiratory Failure" Not yet recruiting NCT04317326
42 The Evaluation of the Sleep-Breathing Treatment Algorithm: AutoEPAP iVAPS Suspended NCT02317042
43 Simplus and Eson Evaluation in Obesity Hypoventilation Syndrome (NZ) Terminated NCT02486380
44 Obesity Hypoventilation Syndrome Prevalence Study Terminated NCT01964339
45 Simplus and Eson Non-Invasive Ventilation (NIV) Evaluation - Germany Terminated NCT02726048
46 Feasibility of a Modified Positive Airway Pressure Device to Treat Sleep Disordered Breathing Terminated NCT02368639
47 European Home Mechanical Ventilation Registry Terminated NCT02315339
48 Telemedicine as a Proposed Solution Towards Efficiency of Healthcare Delivery for Einstein Pulmonary Patients on PAP/NIPPV for Hypercapnia Terminated NCT03353064
49 Microbiologic Contamination of Home Non Invasive Ventilators Terminated NCT03809832
50 Target Volume With a Pressure Controlled Ventilator in Obesity Hypoventilation Syndrome With Persistent Oxygen Desaturations With Continuous Positive Airway Pressure Withdrawn NCT01104610

Search NIH Clinical Center for Obesity-Hypoventilation Syndrome

Sources

Genetic Tests for Obesity-Hypoventilation Syndrome

About this section
Sources

Anatomical Context for Obesity-Hypoventilation Syndrome

About this section

MalaCards organs/tissues related to Obesity-Hypoventilation Syndrome:

40
Heart, Lung, Endothelial, Brain, Retina, Kidney, Skin
Sources

Publications for Obesity-Hypoventilation Syndrome

About this section

Articles related to Obesity-Hypoventilation Syndrome:

(show top 50) (show all 566)
# Title Authors PMID Year
1
OBESITY-HYPOVENTILATION SYNDROME IN SIBLINGS. 57 61
14178614 1964
2
[Obesity and respiratory disorders]. 61 54
19127895 2008
3
Hyperleptinaemia, respiratory drive and hypercapnic response in obese patients. 61 54
17459895 2007
4
Long-term non-invasive ventilation increases chemosensitivity and leptin in obesity-hypoventilation syndrome. 61 54
17189682 2007
5
Severity of RSV infection in Southern European elderly patients during two consecutive winter seasons (2017-2018). 61
33704814 2021
6
The air that we (do not) breathe: lower adipose tissue oxygen availability in patients with obesity hypoventilation syndrome? 61
33758340 2021
7
Markers of adipose tissue hypoxia are elevated in subcutaneous adipose tissue of severely obese patients with obesity hypoventilation syndrome but not in the moderately obese. 61
33758342 2021
8
Adherence to Positive Airway Pressure Therapy in Obesity Hypoventilation Syndrome. 61
33485531 2021
9
Heart Rate Variability Changes by Non Invasive Ventilation in Obesity Hypoventilation Syndrome. 61
33724712 2021
10
Leptin receptor expression in the dorsomedial hypothalamus stimulates breathing during NREM sleep in db/db mice. 61
33624805 2021
11
Long-Term Adherence to Positive Airway Pressure Therapy in Saudi Ambulatory Patients with Obesity Hypoventilation Syndrome and Severe Obstructive Sleep Apnea: A One-Year Follow-Up Prospective Observational Study. 61
33469401 2021
12
[Variation in ventilatory response to CO2 in patients treated by non-invasive ventilation]. 61
33246772 2021
13
Acute hemodynamic effects of non-invasive ventilation in patients with obesity hypoventilation syndrome. 61
33729816 2021
14
Sleep-related breathing disorders and pulmonary hypertension. 61
32747397 2021
15
[Novel therapies in respiratory management]. 61
33507663 2021
16
Obesity Hypoventilation: Traditional Versus Nontraditional Populations. 61
33131656 2020
17
Long-Term Mechanical Ventilation: Recommendations of the Swiss Society of Pulmonology. 61
33302274 2020
18
Perioperative Care and Medication-related Hypoventilation. 61
33131658 2020
19
Portuguese adaptation of the S3-non-invasive ventilation (S3-NIV) questionnaire for home mechanically ventilated patients. 61
33388296 2020
20
[Obesity hypoventilation syndrome and initial compliance with non-invasive ventilation]. 61
33071059 2020
21
Ventilatory response to exercise is preserved in patients with obesity hypoventilation syndrome. 61
32895118 2020
22
Comprehensive care of a patient with obesity of BMI >70 kg/m2. 61
33372011 2020
23
Pulmonary embolism in obesity-hypoventilation syndrome. 61
32745286 2020
24
Sleep-disordered breathing in severe mental illness: clinical evaluation of oximetry diagnosis and management limitations. 61
33245500 2020
25
Long-term survival following initiation of home non-invasive ventilation: a European study. 61
32895315 2020
26
CPAP titration failure is not equivalent to long-term CPAP treatment failure in patients with obesity hypoventilation syndrome: a case series. 61
32713421 2020
27
Survival and end-of-life aspects among subjects on long-term noninvasive ventilation. 61
33209213 2020
28
Effectiveness of different treatments in obesity hypoventilation syndrome. 61
32553827 2020
29
Long-term adherence to home mechanical ventilation: a 10-year retrospective, single-centre cohort study. 61
33214917 2020
30
Overlooking Obesity Hypoventilation Syndrome: The Need for Obesity Hypoventilation Syndrome Staging and Risk Stratification. 61
33000959 2020
31
Long-term outcome with focus on pulmonary hypertension in Obesity Hypoventilation Syndrome. 61
32506595 2020
32
AVAPS-AE versus ST mode: A randomized controlled trial in patients with obesity hypoventilation syndrome. 61
32052923 2020
33
Prevalence of chronic kidney disease in obesity hypoventilation syndrome and obstructive sleep apnoea with severe obesity. 61
32841847 2020
34
Elucidating Predictors of Obesity Hypoventilation Syndrome in a Large Bariatric Surgery Cohort. 61
32526148 2020
35
Long-term Noninvasive Ventilation in Obesity Hypoventilation Syndrome Without Severe OSA: The Pickwick Randomized Controlled Trial. 61
32343963 2020
36
A network meta-analysis of different positive airway pressure interventions in obesity hypoventilation syndrome. 61
32789956 2020
37
Long-term effectiveness of CPAP in patients with severe obesity-hypoventilation syndrome. 61
32851587 2020
38
Home mechanical ventilation: quality of life patterns after six months of treatment. 61
32807149 2020
39
Obesity-Hypoventilation Syndrome: Baseline Hemodynamic Status and Impact of non-Invasive Ventilation. 61
31882192 2020
40
Letter to the Editor: Obesity hypoventilation syndrome and severe COVID-19. 61
32333938 2020
41
Long-Term Noninvasive Ventilation in the Geneva Lake Area: Indications, Prevalence, and Modalities. 61
32243941 2020
42
Sodium glucose cotransporter2 inhibitor-possible treatment for patients with diabetes, pulmonary disease and CO2 retention. 61
32088396 2020
43
Cost-effectiveness of positive airway pressure modalities in obesity hypoventilation syndrome with severe obstructive sleep apnoea. 61
32217780 2020
44
Positive airway pressure in obesity hypoventilation syndrome: is it worth it? 61
32217782 2020
45
Sudden death after oxygen toxicity seizure during hyperbaric oxygen treatment: Case report. 61
32557424 2020
46
The Effect of Hospital Discharge with Empiric Noninvasive Ventilation on Mortality in Hospitalized Patients with Obesity Hypoventilation Syndrome. An Individual Patient Data Meta-Analysis. 61
32023419 2020
47
Obesity hypoventilation syndrome treated with non-invasive ventilation: Is a switch to CPAP therapy feasible? 61
31597227 2020
48
Obesity hypoventilation syndrome: Stretching the health dollar. 61
31709691 2020
49
Weight Loss Interventions as Treatment of Obesity Hypoventilation Syndrome. A Systematic Review. 61
31978317 2020
50
BPAP is an effective second-line therapy for obese patients with OSA failing regular CPAP: A prospective observational cohort study. 61
31407464 2020
Sources

Variations for Obesity-Hypoventilation Syndrome

About this section
Sources

Expression for Obesity-Hypoventilation Syndrome

About this section
Search GEO for disease gene expression data for Obesity-Hypoventilation Syndrome.
Sources

Pathways for Obesity-Hypoventilation Syndrome

About this section

Pathways related to Obesity-Hypoventilation Syndrome according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1
Common Cytokine Receptor Gamma-Chain Family Signaling Pathways 64
Show member pathways
 12.23 RETN LEP IL6 ADIPOQ
3
Mesenchymal Stem Cell Differentiation Pathways and Lineage-specific Markers 64
11.31 LEP IL6 ADIPOQ
4
Adipocytokine signaling pathway 36
11.3 LEP ADIPOQ
5
Lung fibrosis 1
11.23 IL6 CCL5
6
Interleukin-10 signaling 65
11.09 IL6 CCL5
7
Adipogenesis 1
11.04 RETN LEP IL6 ADIPOQ
8
Differentiation of white and brown adipocyte 1
10.77 LEP ADIPOQ
9
Transcription factor regulation in adipogenesis 1
10.47 LEP IL6 ADIPOQ
Sources

GO Terms for Obesity-Hypoventilation Syndrome

About this section

Cellular components related to Obesity-Hypoventilation Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.35 RETN LEP IL6 CCL5 ADIPOQ
2 extracellular space GO:0005615 9.02 RETN LEP IL6 CCL5 ADIPOQ

Biological processes related to Obesity-Hypoventilation Syndrome according to GeneCards Suite gene sharing:

(show all 20)
# Name GO ID Score Top Affiliating Genes
1 signal transduction GO:0007165 9.83 RETN LEP IL6 CCL5 ADIPOQ
2 circadian rhythm GO:0007623 9.59 LEP ADIPOQ
3 response to nutrient GO:0007584 9.58 LEP ADIPOQ
4 response to insulin GO:0032868 9.58 RETN LEP
5 response to nutrient levels GO:0031667 9.57 LEP ADIPOQ
6 response to glucocorticoid GO:0051384 9.56 IL6 ADIPOQ
7 glucose metabolic process GO:0006006 9.55 LEP ADIPOQ
8 positive regulation of smooth muscle cell proliferation GO:0048661 9.54 IL6 CCL5
9 glucose homeostasis GO:0042593 9.54 LEP IL6 ADIPOQ
10 positive regulation of interleukin-8 production GO:0032757 9.52 IL6 ADIPOQ
11 negative regulation of fat cell differentiation GO:0045599 9.51 IL6 ADIPOQ
12 regulation of insulin secretion GO:0050796 9.5 LEP IL6 CCL5
13 fatty acid beta-oxidation GO:0006635 9.49 LEP ADIPOQ
14 monocyte chemotaxis GO:0002548 9.48 IL6 CCL5
15 regulation of angiogenesis GO:0045765 9.46 LEP IL6
16 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.43 LEP IL6 CCL5
17 negative regulation of lipid storage GO:0010888 9.4 LEP IL6
18 positive regulation of T cell proliferation GO:0042102 9.33 LEP IL6 CCL5
19 response to activity GO:0014823 9.13 LEP IL6 ADIPOQ
20 positive regulation of JAK-STAT cascade GO:0046427 8.8 LEP IL6 CCL5

Molecular functions related to Obesity-Hypoventilation Syndrome according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cytokine activity GO:0005125 9.13 IL6 CCL5 ADIPOQ
2 hormone activity GO:0005179 8.8 RETN LEP ADIPOQ
Sources

Sources for Obesity-Hypoventilation Syndrome

About this section
3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
20 GARD
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
53 NINDS
54 Novoseek
56 OMIM via Orphanet
57 OMIM® (Updated 05-Apr-2021)
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 Tocris
70 UMLS
71 UMLS via Orphanet
The MalaCards human disease database index: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Content
Loading form....